Skip to content

Clinical Application of Comprehensive Intervention for PED Based on Neuroregulatory Mechanism

Clinical Application of Comprehensive Intervention Scheme for Post-extubation Dysphagia Based on Neuroregulatory Mechanism

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06386159
Enrollment
69
Registered
2024-04-26
Start date
2024-03-15
Completion date
2025-07-30
Last updated
2024-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-extubation Dysphagia

Keywords

post-extubation dysphagia, electrical stimulation

Brief summary

This study aims to establish a practical comprehensive intervention program for dysphagia after extubation in adult ICU patients based on the best evidence of its assessment and intervention, through expert panel discussion and Delphi method. In addition, combining the preliminary experimental results of vagus nerve stimulation applied to PED patients, we further develop a comprehensive intervention program for dysphagia after extubation based on neural regulation mechanism. Finally, the implementation effect of this PED comprehensive intervention program based on neural regulation mechanism will be verified through clinical application.

Interventions

OTHERComprehensive Intervention or Comprehensive Intervention Combined with Electrical vagus nerve stimulation

Comprehensive intervention includes multidisciplinary collaboration, screening and assessment, oral sensory training, oral motor training, respiratory training, and feeding management. Transcutaneous electrical stimulation of the vagus nerve at the lateral neck was performed by rehabilitation therapists. The cervical vagus nerve accompanies the carotid artery and is located at the groove between the trachea and the sternocleidomastoid muscle, which can be located by touching the carotid pulse. The two electrodes were pasted along the path of the cervical vagus nerve.

Sponsors

Jinhua Municipal Central Hospital
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Patients who met the diagnostic criteria of PED were changed to SSA score ≥24 2. aged from 18 to 90 years old; 3. oral or nasotracheal intubation for ≥48 hours; 4. Clear mind 5. Glasgow score ≥13 points, with good cooperation ability; 6. There was no contraindication to oral feeding after extubation

Exclusion criteria

1. Other diseases that affect swallowing function (such as stroke, Parkinson's disease, head and neck deformity, radiotherapy after head and neck cancer, burn with inhalation injury, esophageal cancer, chronic obstructive pulmonary disease, etc.); 2. history of reflux and aspiration; 3. tracheotomy; 4. isolation treatment due to respiratory infectious diseases; 5. the presence of implantable electronic devices (e.g., pacemakers, cochlear implants); 6. Traumatic vagus recurrent laryngeal nerve injury, history of vagus nerve surgery, or vagus nerve injury

Design outcomes

Primary

MeasureTime frameDescription
functional oral intake scale(FOIS)up to 90 daysFOIS consists of seven levels: ① Score 1, unable to eat orally at all; ② Score 2, dependent on tube feeding, minimum attempt to eat food or liquid; ③ Score 3, dependent on tube feeding, taking single texture food or liquid orally; ④ Score 4, completely oral intake of single texture food; ⑤ score 5: fully oral intake of a variety of food textures, but with special preparation or compensation; ⑥6 points, completely oral feeding without special preparation, but with special food restriction; ⑦7 points, complete oral feeding without restriction, the higher the score, the better the swallowing function of the patient. In this study, a FOIS score of 6-7 was defined as full oral feeding
standardized Swallowing Assessment(SSA)up to 90 daysThe first part is the clinical examination.The second part involves observing the patient's ability to swallow 5 mL of water, repeated three times. If there are no abnormalities detected in the above examinations, the amount of water for swallowing is then increased to 60 mL. To obtain the total score, the scores from all three parts are summed up.

Secondary

MeasureTime frameDescription
Rate of Re-intubation after Endotracheal Intubationup to 90 daysThe rate of re-intubation during the intervention period after extubation in patients who have undergone endotracheal intubation
Incidence of aspiration within one week after extubationup to 90 daysIncidence of aspiration within one week after extubation
The incidence of aspiration pneumonia within one week after extubationup to 90 daysThe incidence of aspiration pneumonia within one week after extubation
Inflammation-related indicators: serum C-reactive protein (CRP)up to 90 daysMonitoring of patients' inflammatory marker
Inflammation-related indicators: serum interleukin-6 (IL-6)up to 90 daysMonitoring of patients' inflammatory marker
Rate of total oral feeding after the interventionup to 90 daysAfter the intervention, the patient's score on the Functional Oral Intake Scale (FOIS) was between 6 and 7, indicating that the patient has recovered the ability to eat orally.
Inflammation-related indicators: high mobility group box-1 protein (HMGB1)up to 90 daysMonitoring of patients' inflammatory marker
Days of ICU hospitalizationup to 90 daysDays of ICU hospitalization
Total days of hospitalizationup to 90 daysTotal days of hospitalization
In-hospital survival rateup to 90 daysThe number of patients who survive during hospitalization
Inflammation-related indicators: serum procalcitonin, acetylcholine (ACh)up to 90 daysMonitoring of patients' inflammatory markers
Duration of Enteral Nutrition Tube Indwellingup to 90 daysThe duration of the nasogastric tube or nasointestinal tube indwelling in the patient

Countries

China

Contacts

Primary ContactXiuqin Feng
fengxiuqin@zju.edu.cn13757119151

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026